Arrow acquisition boosts Watson's 2009 performance
24 February 2010
Simon Varcoe
Please Login to read the full article.
24 February 2010
Simon Varcoe
simon.varcoe@informa.com
Watson Pharmaceuticals' acquisition of Arrow in early December helped to boost its full-year 2009 net revenues to $2.8 billion, 10% higher than in 2008.
The acquisition, which cost Watson $1.75 billion, particularly boosted Watson's generic revenues, though these were offset by lower sales...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
